Press release: Innomech teams up with biotechnology company for end-of-line test systems
8 July 2019One of the world’s leading biotechnology groups has appointed GB Innomech (Innomech) to develop a sophisticated, automated end-of-line testing system for a new drug delivery pen. Innomech was first asked to advise on the feasibility of automating an existing quality control process for the multi-dose, dial-a-dose injection pen before being appointed to design and build two machines.
Innomech’s new easy-to-use system incorporates calibrated measuring devices to check and record over 20 parameters on four key areas of the pen while simulating use of the assembled, multi-part injection device. For example, the system measures the forces required to fire the trigger or adjust the dose control knob before comparing them against agreed tolerances to confirm products comply fully with the required specification. The fully automated test routine takes approximately 30 seconds to complete.